Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial

Autor: Jeroen van Dillen, Aafke Bruinsma, Frank P.H.A. Vandenbussche, Esteriek de Miranda, Judit K. J. Keulen, Ben W.J. Mol, Anton H. van Kaam, Joep C. Kortekaas, Patrick M. M. Bossuyt, Martijn A. Oudijk, Joris A. M. van der Post, Ruben G. Duijnhoven
Přispěvatelé: Graduate School, Obstetrics and Gynaecology, Amsterdam Reproduction & Development (AR&D), APH - Personalized Medicine, APH - Methodology, Epidemiology and Data Science, Neonatology, ARD - Amsterdam Reproduction and Development
Rok vydání: 2019
Předmět:
Psychological intervention
law.invention
0302 clinical medicine
Randomized controlled trial
Interquartile range
law
Pregnancy
Infant Mortality
Outcome Assessment
Health Care

Medicine
030212 general & internal medicine
Netherlands
education.field_of_study
030219 obstetrics & reproductive medicine
Labor
Obstetric

Obstetrics
Incidence (epidemiology)
Absolute risk reduction
Obstetrics and Gynecology
Gestational age
General Medicine
3. Good health
Meconium Aspiration Syndrome
Reconstructive and regenerative medicine Radboud Institute for Molecular Life Sciences [Radboudumc 10]
Apgar score
Female
Intracranial Hemorrhages
Adult
Risk
medicine.medical_specialty
Adolescent
Population
Gestational Age
03 medical and health sciences
Young Adult
All institutes and research themes of the Radboud University Medical Center
Intensive Care Units
Neonatal

Humans
Brachial Plexus
Labor
Induced

education
Watchful Waiting
Fetal Death
Perinatal Mortality
business.industry
Cesarean Section
Other Research Radboud Institute for Health Sciences [Radboudumc 0]
Infant
medicine.disease
Confidence interval
business
Zdroj: BMJ. British Medical Journal (Online), 364
Obstetrical & gynecological survey, 74(7), 381-383. Lippincott Williams and Wilkins
BMJ (Clinical research ed.), 364:l344. British Medical Association
ISSN: 1756-1833
0029-7828
0959-8146
Popis: Objective To compare induction of labour at 41 weeks with expectant management until 42 weeks in low risk women. Design Open label, randomised controlled non-inferiority trial. Setting 123 primary care midwifery practices and 45 hospitals (secondary care) in the Netherlands, 2012-16. Participants 1801 low risk women with an uncomplicated singleton pregnancy: randomised to induction (n=900) or to expectant management until 42 weeks (n=901). Interventions Induction at 41 weeks or expectant management until 42 weeks with induction if necessary. Primary outcome measures Primary outcome was a composite of perinatal mortality and neonatal morbidity (Apgar score Results Median gestational age at delivery was 41 weeks+0 days (interquartile range 41 weeks+0 days-41 weeks+1 day) for the induction group and 41 weeks+2 days (41 weeks+0 days-41 weeks+5 days) for the expectant management group. The primary outcome was analysed for both the intention-to-treat population and the per protocol population. In the induction group, 15/900 (1.7%) women had an adverse perinatal outcome versus 28/901 (3.1%) in the expectant management group (absolute risk difference −1.4%, 95% confidence interval −2.9% to 0.0%, P=0.22 for non-inferiority). 11 (1.2%) infants in the induction group and 23 (2.6%) in the expectant management group had an Apgar score v expectant management n=102 (11.3%)) or in caesarean section rate (both groups n=97 (10.8%)). Conclusions This study could not show non-inferiority of expectant management compared with induction of labour in women with uncomplicated pregnancies at 41 weeks; instead a significant difference of 1.4% was found for risk of adverse perinatal outcomes in favour of induction, although the chances of a good perinatal outcome were high with both strategies and the incidence of perinatal mortality, Apgar score Trial registration Netherlands Trial Register NTR3431.
Databáze: OpenAIRE